BioDelivery Sciences (BDSI) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts BDSI Hot Sheet
Price: $5.59 --0%
Financial Fact:
General and administrative: 12.05M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
General and administrative: 12.05M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
BioDelivery Sciences (NASDAQ: BDSI) reported Q2 EPS of ($0.31), in-line with the analyst estimate of ($0.31). Revenue for the quarter came in at $5 million versus the consensus estimate of $3.35 million.
For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fabrinet (FN) Tops Q1 EPS by 15c; offers guidance
- Clorox (CLX) Tops Q1 EPS by 48c; maintains guidance
- Backblaze, Inc (BLZE) Tops Q3 EPS by 4c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
